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consideration of gut–brain interactions may be important 
for treatment regarding the determination of target weight, 
rapidity of weight gain, refeeding methods and composi-
tion of the diet which might all be of importance to improve 
long-term outcome of one of the most chronic psychiatric 
disorders of adolescence.
Keywords Anorexia nervosa · Microbiome · Gut–brain 
interaction · Starvation · Autoimmune disease
Introduction
The Hippocratic concept of positive health dates back to 
the fifth century B.C. and postulates that adequate nutri-
tion is an important component of a long and healthy life 
[1]. Nutrition comprises macronutrients (carbohydrates, 
proteins and fat) and micronutrients (vitamins and miner-
als) to supply energy and enable an organism to grow and 
function properly. Although most people consider sufficient 
and balanced eating as a basic drive to maintain well-being, 
anorexia nervosa (AN) is characterized by insufficient food 
intake and poor diet, which lead to a significantly low body 
weight and severe danger to the individual’s health. Addi-
tionally, patients with AN suffer from severe weight pho-
bia; in many but not all cases, there is a lack of recognition 
of the seriousness of the illness [2].
Some 30 years ago, the aetiology of AN was explained 
by a psychosomatic family model [3, 4]. Herein, nutritional 
rehabilitation and weight gain were not considered to be 
of primary importance to the healing process. Today, it is 
well-known that a higher body mass index (BMI) at the 
end of treatment correlates with a better overall outcome 
[5] and that a normalization of body weight is necessary 
to prevent severe somatic sequelae such as osteoporosis 
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and infertility [6, 7]. Moreover, it is well-established that 
weight gain is a potent agent against comorbid mental dis-
orders of AN, especially depression [8, 9].
Most mental disorders emerge by an interaction between 
a person’s biological disposition and environmental influ-
ences, i.e. by an interaction of “nature” and “nurture”. In 
AN, the latter is to be taken literally. In animals and healthy 
individuals, eating is both a motivating and appetitive 
behaviour that is highly reinforced and rewarded by certain 
neurocircuits in the brain (for a review, see [10]). How-
ever, this “core eating network” [10] seems to be severely 
affected in patients with eating disorders, especially AN. 
These individuals seem to process food cues differently in 
comparison to healthy eaters, exhibit decreased anticipation 
of food taste and often show strong regulatory responses 
enabling control and restraint of food intake [10]. However, 
it remains unclear whether these changes are primary in 
origin, and thus a cause of the eating disorder, or whether 
they appear during the illness as secondary effects.
There is emerging evidence of important links between 
the gut microbiome and the CNS, which might be depicted 
as “a gut feeling for the brain” [11] (for a review, see [12]). 
Humans sustain a symbiotic relationship with the micro-
biome in their gut, which consists of approximately 1014 
cells; thus there are ten times more bacteria than cells in the 
average human body [13]. The highest bacterial concentra-
tions are found in the colon with approximately 1012 per 
gram [14]. We supply our microbiota with food, and they 
compensate us with important health benefits in relation to 
digestion, growth and defence against pathogens [11, 15].
We have recently learned that malnutrition and long-
term dieting have a substantial and reproducible effect on 
the gut microbiome and its impact on the brain, which is 
likely related to the development of psychopathology and 
psychiatric disorders [15]. There is growing evidence that 
the gut microbiome also plays an important role in the 
development and persistence of eating disorders, especially 
AN [16].
Among all age groups, less than 50% of patients with 
AN fully recover [17], and the mortality risk is the high-
est of all psychiatric disorders [18]. Medication has a very 
limited, if any role in the treatment of AN, and psychother-
apeutic interventions are only moderately effective (for a 
review, see [19]). To make progress in treatment, a more 
“brain-directed therapy” [20] is likely necessary to over-
come this often disabling disease.
Thus, the aim of this article is to present recent findings 
on the gut–brain interaction that may be of relevance to the 
pathophysiology of eating disorders, and for AN in particu-
lar. In part because this research is still at an early stage, 
several results are contradictory, and most findings are 
based on animal models that may not be easily transferred 
to humans. While we do not fully review all substantial 
aspects of gut–brain interaction for weight regulation or 
psychiatric disorders, our assessment aims to focus on the 
influences of malnutrition, the process of refeeding and 
their presumable impact on the course of AN. “Nutritional 
medicine” and microbiota-modulating strategies may be 
promising determinants of the healing process and outcome 
of AN.
Communication pathways between the gut 
microbiome and the brain
The gut is the most heavily bacterially colonized area 
of the human body, with greater bacterial numbers in the 
colon than in the upper intestine (see above), in addition 
to differences in composition between the bacteria in the 
gut lumen and those near the mucus layer [21]. One of the 
most important “tasks” of the gut microbiome is contribut-
ing to the protection of the intestinal barrier, which must 
prevent the passage of pathogenic microorganisms and 
toxic substances into systemic circulation. Certain periods 
of life seem to involve particular vulnerability to changes 
in gut permeability, e.g. early life and old age [22]. There 
are several pathways by which changes in the intestinal 
barrier might impact brain homeostasis, particularly neu-
roendocrinological alterations, neurotransmission, neuro-
genesis and neuroinflammation, either by direct passage 
to the brain or by the vagus nerve, which acts as the main 
pathway from the lumen of the gut to the nucleus solitarius 
in the medulla oblongata [11].
Neuroendocrinological pathways—Hypothalamic–
Pituitary–Adrenal (HPA)‑axis
In animal models and human studies, the experience of 
stress is linked to an increase in the permeability of the 
intestinal barrier, which might be mediated by—among 
other factors—hypothalamic hormones, especially CRH 
[22]. Acute stress increases gastrointestinal and blood–
brain barrier permeability through the activation of mast 
cells, which express high-affinity receptors for CRH [15]. 
Conversely, in germ-free (GF) rodents, higher levels of 
ACTH and CRH are observed after exposure to stress 
compared to conventionally colonized animals, suggesting 
that the gut microbiome contributes to the downregulation 
of the HPA-axis. Notably, this effect appears dependent 
on specific bacterial taxa, as only certain species such as 
Lactobacillus salivarius were able to attenuate the stress 
response [11].
In humans, even relatively small acute stress situa-
tions such as public speaking are followed by an increase 
in intestinal permeability, although only in those who also 
respond with elevated cortisol levels [23].
Eur Child Adolesc Psychiatry 
1 3
AN is associated with elevated serum, urinary and sali-
vary cortisol levels in the acute state, as well as with a lack 
of cortisol suppression on overnight dexamethasone and 
dexamethasone suppression-CRH stimulation testing [24, 
25]. Thus, it may be hypothesized that AN-specific aberra-
tion of the HPA-axis could contribute to the dysfunction of 
the intestinal barrier that is observed in an animal model of 
AN (see below, [26]).
Neurotransmission
It is increasingly recognized that gut microorganisms 
have a notable effect on the development and regulation 
of peripheral and central serotonergic function, especially 
in the hippocampus. Yano et al. [27] propose a model 
in which products of microbial fermentation, e.g. short-
chain fatty acids (SCFA, see below) and bile acids (see 
below), directly act on enterochromaffin cells, and thus 
promote the release of serotonin, which influences gastro-
intestinal mobility and platelet function. GF mice display 
depressed levels of serotonin in plasma compared to con-
ventionally raised mice [28, 29]. However, they display 
less anxiety- and depression-like behaviour than naturally 
raised mice [30, 31]. Anxiety and depression are closely 
linked to disturbed serotonin metabolism [32]. In contrast 
to the findings by Wikoff et al. [28] in plasma extracts of 
GF mice, significantly increased hippocampal levels of 
5-hydroxytryptamine (5-HT) and 5-hydroxyindoleacetic 
acid (5-HIAA), the main metabolites of serotonin, were 
found in developing GF mice compared to naturally raised 
mice. A sustained absence of microorganisms in these ani-
mals was observed to induce a 1.3-fold increase in 5-HT, 
which compares to that induced by antidepressants such as 
SSRIs (for a review, see Clarke [33]). This increase appears 
to be sex-specific as it was only found in developing male 
GF mice. The reasons for this sex difference are not well 
explored, but are probably linked to the menstrual cycle 
and the influence of oestrogen on the serotonergic system. 
Notably, elevated levels of 5-HT are maintained when these 
mice are colonized with a normal microbiota later in life, 
which also demonstrates that the early life period plays an 
important role in configuring the gut–brain interaction [33].
A recent study in patients with major depression demon-
strated that patients differed from normal controls in either 
a predominance of some potentially harmful gut bacteria 
or a reduction of beneficial bacterial groups [34]. Further, 
a large evaluation of medical record-based data in the UK 
showed that repeated use of antibiotics was associated with 
a significant increase in depressive and anxious symptoms 
[35].
It is suspected that the serotonergic system is severely 
altered in AN. During the active state of the illness, patients 
have a significant reduction in CSF-5-HIAA in comparison 
to healthy controls; in long-term weight-restored patients, 
CSF-levels of 5-HIAA are elevated, which is generally 
related to disorders of anxiety and obsession [36]. A dys-
function of the serotonergic system involving 5-HT-recep-
tors and 5-HT-transporters in AN was also confirmed by 
brain-imaging studies (for a review, see [37]). However, 
medications targeting serotonergic dysfunction, such as 
SSRIs, are not proven effective in AN (for a review, see 
[38]).
Neurogenesis
Brain-derived neurotrophic factor (BDNF) is a nerve 
growth factor known to influence neuronal development, 
increase synapse plasticity especially in the hippocampus, 
and confer protection against stress-induced damage [39]. 
BDNF function is linked to mood, stress tolerance and cog-
nitive function such as memory. Recent animal research 
suggests that the gut microbiome may influence the expres-
sion of BDNF in the brain, although the mechanism is 
not yet clear [11]. Prolonged administration of antibiotics 
results in a reduction [40], while pre- or probiotics (see 
below) seem to enhance hippocampal BDNF levels [41, 
42]. In the absence of gut bacteria, the expression of BDNF 
in male mice is lowered in comparison to conventionally 
colonized mice, while it is increased by prebiotic feeding 
[43].
We are unaware of any studies on the association 
between the microbiome and BDNF in humans.
In AN, BDNF levels are reduced in acutely ill patients 
[44], but increase with short-term weight gain [45]. Thus, 
it could be hypothesized that diet-associated changes in 
the microbiome contribute to different stage-related levels 
of BDNF in the brains of AN patients, which might also 
influence cognitive functioning (e.g. psychomotor speed) 
[45]. Möhle et al. [46] directly showed that neurogenesis 
in the hippocampus was reduced in mice after antibiotic 
treatment, which resulted in impaired memory functions, 
whereas probiotic intake completely restored neurogenesis 
and memory functions. However, it remains to be demon-
strated whether similar phenomena occur in humans.
Neuroinflammation
The intestinal barrier normally prevents pathogenic micro-
organisms from spreading into systemic circulation. How-
ever, the so-called “leaky gut” (increased intestinal permea-
bility) might facilitate the transfer of potentially pathogenic 
members of the microbiota (i.e. “pathobionts”), metabo-
lites, toxins or lipopolysaccharides from the gut lumen to 
the lamina propria and on to the mesenteric lymph nodes, 
from which they may reach systemic circulation, especially 
in the case of an aberrant immune response [12, 15, 47]. 
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This phenomenon was observed both in animal models 
for depression [48] and in depressed humans [47]. Once 
in circulation, the bacteria and other gut luminal contents 
stimulate the output of pro-inflammatory peripheral and 
central cytokines, the latter influencing neuronal function. 
Enhanced levels of IgA- and IgM antibodies against bac-
terial lipopolysaccharide, the structural component of the 
external membrane of Gram-negative bacteria, are observed 
in depressed patients, especially in those with chronic dis-
orders [49]. However, it is not yet clear what comes first; 
increased gut permeability could induce mucosal inflam-
mation followed by systemic inflammation; conversely, 
systemic inflammation could disturb intestinal barrier func-
tion, thus leading to an increased bacterial translocation 
and fuelling of systemic inflammation [12].
An increased risk for autoimmune disorders is observed 
in AN, especially for those involving the gastrointestinal 
tract (see below, [50]).
Short‑Chain Fatty Acids (SCFAs) with neuroactive 
qualities
Short-chain fatty acids mainly represent the product of 
fermentation of partially digestible and non-digestible car-
bohydrates, namely dietary fibre, by the microbiome [51]. 
The most important SCFAs are acetic acid, propionic acid 
and butyric acid, which can act as “signalling molecules” 
and affect the physiology of the host organism, such as 
influencing the ph-level of the colon, controlling the gut 
transit time, metabolizing glucose and modifying appe-
tite and energy homeostasis [11, 52–54]. SCFAs are also 
able to cross the brain–blood barrier and impact neural cir-
cuits [55]. They are involved in regulating the expression 
of neuropeptides, such as PYY and ghrelin [56] and are 
associated with antidepressant effects in animal models via 
higher concentrations of BDNF.
Starvation and the gut microbiome
Mouse models provide evidence that the transfer of 
microbiota from genetically or nutritionally induced 
obese mice to GF mice can lead to obesity and associated 
metabolic disturbances in the host animals [57, 58]. In 
contrast, kwashiorkor is a severe form of acute malnutri-
tion often observed in developping countries that is prob-
ably worsened by a protein-deficient diet. It was recently 
shown that the consequences of this type of malnutrition 
are affected by the gut microbiome and vice versa [59]. 
Frozen bacterial species from children with kwashior-
kor could be transplanted into GF mice; the combination 
of the transplanted kwashiorkor species with the Afri-
can diet produced significant weight loss in these mice 
associated with severe metabolic disturbances. Although 
symptoms of kwashiorkor could be alleviated by better 
nutrition, symptoms returned when the African diet was 
re-implemented.
Starvation-induced changes in the gut microbiome were 
also found in an acute and chronic starvation animal model 
using activity-based anorexia (ABA), which is the most 
widely utilized rodent model of AN simulating weight loss 
by food restriction and hyperactivity with the help of access 
to a running wheel (e.g. [60]). After the ABA mice lost a 
substantial amount of weight (approximately 20%), a histo-
logical investigation of the colon revealed decreased thick-
ness of the muscularis layer and significantly increased 
permeability of the colon [26]. These alterations observed 
in an animal model for AN suggest that intestinal barrier 
dysfunction provoked by starvation might also contribute to 
the pathophysiology of AN. In contrast, in an earlier study 
of AN patients by Monteleone et al. [61], a decrease in 
intestinal permeability was found. However, the authors of 
this earlier study used the administration of an oral sugar 
solution of Lactulose/Mannitol excreted in the urine for 
their testing, which mainly examines the permeability of 
the small intestine [62]. In the study of ABA mice by Jesus 
et al. (2014), the permeability of the colon assessed by his-
tological analysis was increased. Moreover, the amount of 
the oral dose of the sugar absorption test excreted in the 
urine does not only depend on the permeability of the intes-
tinal mucosa, but also on other factors, such as gastric emp-
tying, intestinal transit time and renal clearance [62], all of 
which may be disturbed in AN.
In addition, several studies demonstrated an increase 
in intestinal permeability during exercise, which is found 
in the majority of patients with AN, and also represents a 
basic mechanism in the ABA model [63].
A disturbed gut barrier function was also found in other 
disorders associated with malnourishment and in volun-
teered fasting subjects [64, 65].
Previous studies in AN
Until now, our knowledge of the relevance of the gut 
microbiome for the symptomatology of AN is scarce. Very 
few studies investigated the composition of the intesti-
nal microbiome during the acute and recovered states of 
AN. A single culture-based case study of an AN patient at 
admission identified 11 previously unknown bacterial spe-
cies [66], whereas a study of 25 patients with AN found a 
reduced number of total bacteria and obligate anaerobes 
[67]. Armougom et al. [68] compared the gut microbiome 
in obese individuals, healthy controls (HC) and AN patients 
and found an increased amount of Methanobrevibacter 
smithii in AN [68].
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The first longitudinal results from AN were presented 
by Kleiman et al. [69], who analysed the faecal microbi-
ome in a small number of female, mostly adult AN patients 
collected at admission (n = 16) and discharge after weight 
gain (n = 10) and compared it to HC samples. Weight loss 
at admission was of medium severity. At discharge patients 
(who could be reassessed twice) were still at a rather low 
weight. In comparison to HC, patients with AN displayed 
significantly reduced alpha diversity (describing the within-
sample diversity) in the state of a low BMI. After weight 
gain, there was an increase in alpha diversity, although it 
remained lower than in HC [69]. Notably, differences in 
overall diversity and the abundances of individual bacterial 
groups were significantly associated with eating disorder 
psychopathology and depression scores, a finding consist-
ent with the results of other studies showing associations 
between the gut microbiome and behaviour (e.g. [34]).
In a very recent German study from the University of 
Tuebingen [70], the results of Kleiman et al. [69] were for the 
most part confirmed in their much larger sample of 55 individ-
uals, which were predominantly adults with a mean BMI of 
approximately 15 kg/m2. Although alpha diversity was lower 
in AN patients than in HC at admission, the difference was not 
statistically significant. Furthermore, as already observed in 
the study by Kleiman et al. [69], there was again a significant 
increase in alpha diversity in AN patients after weight gain. 
Nevertheless, AN patients’ microbiome after weight gain still 
resembled that of patients at the beginning of treatment more 
than that of HC in terms of beta diversity (inter-individual var-
iability). However, BMI was still very low (mean BMI 17.7) at 
the second assessment point, so that the effect of a more nor-
malized body weight could not be investigated. Importantly, 
the abundances of individual taxonomic groups differed sig-
nificantly between AN patients and HC, which included an 
increase in mucin-degraders (e.g. Verrucomicrobia and Bifido-
bacteria) and a decrease in butyrate-producers (e.g. Roseburia 
spp.) in AN patients. Mucin-degraders feed on mucus cover-
ing the intestinal wall and potentially contribute to the “leaky 
gut” identified in the ABA animal model of AN (39) men-
tioned above. Moreover, the authors analysed the production 
of short-chain fatty acids (see above) before and after weight 
gain. The concentration of the sub-group of branched-chain 
fatty acids, a product of protein fermentation, was increased 
in AN, although total SCFA production did not differ. They 
further note that branched-chain fatty acids can have negative 
effects on host physiology, e.g. by impacting PYY-releasing 





















Fig. 1  Interaction between the gut microbiome and the brain. While 
food is one of the main influencing factors of the gut microbiome, 
the microbiome in turn is an important influencing factor of body 
weight. Multiple interactions link the microbiome with the brain: 
Gut originating fatty acids (SCFA´s), serotonin, brain-dervied neuro-
trophic growth facotr (BDNF), nervus vagus stimulation and inflam-
matory cytokines appear to impact the brain via various pathways and 
infuence mood and memory function. In turn, brain originating cor-
ticotropin-releasing hormone (CRH), adrenocorticotropic hormone 
(ACTH) and cortisol influence the gut and its microbiome. In AN, a 
“leaky gut” seems to increase transfer of microbiotal antigens into the 
systemic circulation, further increasing inflammation and influencing 
interactions with the brain, potentially also affecting mood and mem-
ory function
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As the peak onset of AN is in adolescence [72], the 
effect of young age and pubertal changes on the microbi-
ome should be explored. An influence of age on the micro-
biome was just below the significance threshold in the 
study by Mack et al. [70]. However, only 11 subjects were 
below the age of 18, including five below the age of 16, 
and profound hormonal changes, which might influence the 
development of the microbiome [73], emerge between the 
age of 12 and 15 years. Thus, it might be important to build 
on the results by Mack et al. [70] and also study younger 
adolescents (Fig. 1).
Gut permeability, inflammation and anorexia 
nervosa
A relationship between immune-mediated disorders and 
the gut microbiome is the subject of recent discussion. The 
microbiome stimulates the release of cytokines and other 
inflammatory mediators [11]. A “leaky gut”, which can be 
provoked by starvation and increases in mucin-degrading 
bacteria, is characterized by antigens traversing the intesti-
nal wall, infiltrating systemic circulation, and thus contrib-
uting to a chronic low-grade inflammation presumed to be 
present in AN. Interestingly, autoantibodies against neuro-
peptides associated with appetite and stress regulation have 
been identified in AN [74, 75]. Moreover, a Finnish study 
conducted between 1995 and 2010 with a large eating-dis-
order cohort (n = 2342) demonstrated an elevated risk for 
autoimmune diseases in these patients [50]. According to 
their dataset assessing 30 autoimmune diseases, the most 
frequent were of endocrinological and gastroenterological 
origin. The lifetime risk (OR) of patients with an eating 
disorder (all diagnoses) to also suffer from an endocrino-
logical disease, mostly diabetes mellitus type 1, was more 
than twice as high (OR 2.4) as for HC, while the risk of 
suffering from a gastroenterological disease was nearly 
twice as high (OR 1.8). The highest rates were found for 
an association with Crohn’s disease (OR 3.09). In other 
previous studies, pro-inflammatory cytokines were shown 
to be increased in acute AN, although they mostly returned 
to normal after nutritional rehabilitation [76] (meta-analy-
sis by Solmi et al. [77]). However, they may play a pivotal 
role in primarily chronic courses. In a recent case report of 
a young woman with co-existing Crohn’s disease and AN, 
the latter was much improved by the prescription of anti-
TNF-alpha treatment [78].
Similar to a putative role in irritable bowel syndrome, 
increased gut permeability might also be associated with 
gastrointestinal complaints frequently occurring in acute 
and chronic AN [79, 80]. However, in the study by Mack 
et al. [70], gastrointestinal symptoms improved, but did not 
completely alleviate with weight gain, although microbial 
richness increased.
Implications for treatment
As discussed above, there is substantial evidence for altera-
tions of the gut microbiome in eating disorders, especially 
AN. These new insights might lend support for new thera-
peutic targets in this often chronic disorder, such as defin-
ing the right target weight, modifications of the refeeding 
process and the composition of the diet, non-bacterial die-
tary supplements and possibly the future use of pre- or pro-
biotics (see below).
Target weight
Although restoration of a healthy body weight is an impor-
tant goal in the treatment of AN, there is no empirically 
derived agreement on the definition of an appropriate tar-
get weight (for a review, see [81]). However, with regard 
to body mass index (BMI), the gut microbiome plays an 
important role. Million et al. [82] analysed the association 
between the gut microbiome and body weight and found 
that the proportion of certain bacteria was significantly cor-
related with BMI. They compared four bacterial species in 
the following four weight classes: obese, overweight, lean 
and anorectic individuals. The abundance of Lactobacil-
lus species was positively correlated with BMI, while Bifi-
dobacterium animalis, Methanobrevibacter smithii and 
Escherichia coli were negatively correlated with BMI. 
Thus, given the differences observed in previous studies 
of AN (i.e. an increase in mucin producers and decrease in 
SFA-producers, [70]), it might be possible that the compo-
sition of the gut microbiome could be used to help deter-
mine individualized target weights for patients (e.g. in the 
context of a restoration of bacterial community structure).
Refeeding and composition of diet
Refeeding practices in AN are mostly based on mainstream 
clinical or expert opinions—there is little empirical evi-
dence for a healthy weight regimen in affected individu-
als. While European clinicians usually start patients on a 
low-calorie diet to avoid the so-called refeeding syndrome, 
American practitioners are less cautious and suggest a 
much higher calorie supply even at the beginning of refeed-
ing (for a review, see [81]).
According to the findings of the Kaye group [83], 
patients with the restricting type of AN need a higher 
quantity of calories to gain the same amount of weight 
as patients with the bulimic type. While this difference is 
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mostly ascribed to higher energy expenditure in patients 
with the restrictive type compared to those with the bulimic 
type, additional involvement of the gut microbiome is con-
ceivable. Indeed, Mack et al. [70] confirmed significant dif-
ferences in microbial community composition according 
to AN subtype. Binge/purge patients often have a higher 
premorbid body weight, which might be associated with 
a different composition of the gut microbiome. The lat-
ter is a key determinant of the transformation of bile acids 
to efficiently take up lipids, carbohydrates and fatty acids 
[84]. The microbiome of both obese mice and humans has 
an increased capacity to harvest energy from nourishment 
[57, 85–87]. Faecal samples transplanted to GF mice from 
obese humans led to increased body and fat mass accom-
panied with obesity-associated metabolic dysfunctions 
[58]. However, normalization of body weight and obesity-
related metabolic perturbations was achievable through co-
housing with lean mice (and hence, exposure to their gut 
microbes through coprophagy) combined with a diet rich 
in vegetables and fruit but low in saturated fats. Thus, one 
might speculate that augmenting gut microbial composi-
tion in combination with certain diets may have potential to 
improve weight restoration in AN.
The composition of the human microbiome has been 
linked to long-term dietary patterns, such as diets in 
Western (animal protein, sugar and fat) and Non-Western 
populations (plant-derived carbohydrates) [80, 88]. How-
ever, the human gut microbiome seems to respond rapidly 
to rigorous short-term macronutrient changes, whereby 
individual diet-driven changes can occur within 3–4 days, 
but reverse in a similar time frame [89]. In an impor-
tant study by David et al. [90], the authors compared the 
effects of a shift in macronutrient intake from usual eat-
ing habits to either an animal-based diet or a plant-derived 
diet. Changes in the composition of the gut microbiome 
occurred only one day after the new diet had reached the 
distal gut, but exclusively in the group on the animal-based 
diet, and the gut microbiome returned to its usual composi-
tion two days after this diet ended. Although there was no 
difference in alpha diversity between the two groups, beta 
diversity (difference in community structure between base-
line and diet) significantly changed in the animal-based 
food group. Notably, in contrast to the participants on the 
vegetarian diet, those on the animal-based diet showed 
significant weight loss, although caloric intake was simi-
lar in both groups. One of the most abundant phyla in the 
microbiota of the animal-based diet group was a bacterium 
with a high bile resistance (Bilophila wadsworthia), which 
is in accordance with our knowledge that a diet rich in fat 
results in higher bile acid production. In mice, growth of 
B. wadsworthia is stimulated by ingesting saturated fats 
from milk; it is important that the expansion rate of B. 
wadsworthia is also associated with the development of 
inflammatory bowel disease in these mouse models [90, 
91]. Thus, we may hypothesize that certain diets—also 
in humans—will contribute to the pathogenesis of bowel 
inflammation.
Why are these findings important for the treatment of 
AN? Before admission, anorexia nervosa patients often 
maintain a vegetarian diet low in fat and high in fibre [92]. 
After hospitalization, diet is often quickly changed to a 
high-calorie diet rich in carbohydrates and fat for nutri-
tional rehabilitation. Moreover, in cases of very severe 
AN, patients are sometimes tube-fed or are given oral liq-
uid supplements. Most oral liquid supplements, especially 
those suitable for tube feeding, are based on cow’s milk, 
e.g. an animal-based food product. Thus, within a very 
short time, we may strongly affect the gut microbiome of 
our patients without being aware of the consequences, such 
as the possible growth of inflammation-inducing bacteria. 
Although two studies investigated the impact of weight 
gain on the gut microbiota (see above, [69, 70]), none so 
far has explored the effect of the diet itself.
Pre‑ and probiotics
Gibson and Roberfroid [93] defined a prebiotic as a “non-
digestible food ingredient that beneficially affects the host 
by selectively stimulating the growth and/or activity of one 
or a limited number of bacteria in the gut”. Currently, the 
selectivity criterion is left out, and a prebiotic is defined as 
a “substance that induces the growth of microorganisms 
that contribute to the well-being of their host” (Wikipedia, 
assessed 7/7/2016 [94]; for a review, see [95]). The most 
well-known prebiotics to impact the gut–brain axis are 
fructans (such as inulins and oligofructose) and glucans 
(such as galacto-oligosaccharides) [11]. The latter have 
been demonstrated to improve intestinal barrier function 
in rodents [96]. More recently, substances such as pectins 
and milk oligosaccharides are also included among prebiot-
ics. It is hypothesized that metabolic function of the organ-
ism can be improved and low-grade inflammation reduced 
by altering the gut microbiome with the help of prebiotics 
[87].
Other studies suggest that prebiotics may be effective in 
the treatment of depressive or anxious states and cognitive 
function. Glucans and polydextrose were shown to reduce 
anxiety-related behaviour in rats [97] and to attenuate stress 
response in healthy adult probands [98].
A probiotic is defined as living component of the micro-
biota administered to humans or animals that are associ-
ated with health benefits for the host. In several studies, 
a reduction of intestinal permeability was reported, e.g. 
in pre-term infants, in children with atopic dermatitis and 
irritable bowel syndrome after application of probiot-
ics (for a review, see [12]). Möhle et al. [46] showed that 
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after severely reducing the gut microbiome with several 
antibiotics, neuropsychological deficits, such as learning 
impairments and reduced neurogenesis in the hippocam-
pus, could be induced in mice. These impairments could 
be reversed by orally administering an over-the-counter 
mix of probiotic bacteria. Although an effect of probiotics 
on depressive- and anxiety-like behaviour in mice has been 
observed [99], reports involving larger human samples are 
still lacking. Mazurak et al. [100] analysed the evidence of 
probiotic use in irritable bowel syndrome and criticised that 
studies suffer from heterogeneity in sample sizes, duration 
of treatment and concentration of probiotics. In a system-
atic review by Kristensen [101] including seven studies 
between 2013 and 2015, no significant effect of probiot-
ics on faecal microbiota composition in healthy adults was 
found when compared to placebo. Moreover, there are no 
studies on the benefit of pre- or probiotics in AN.
It is beyond the scope of this article to discuss the ben-
efit of pre- or probiotics in more detail. Sheridan and coau-
thors [102] assert that the type of malnutrition should be 
strictly defined and the target of the intervention should be 
specified before administering pre- or probiotics to under-
nourished patients. In addition, it should be kept in mind 
that there are differences in the type of malnutrition caused 
by famine, old age or somatic disorders in comparison to 
AN patients, who commonly ingest “healthy low caloric 
food” such as a vegetarian diet, which will most likely also 
result in different effects on the microbiome.
Conclusions
There is growing evidence that the gut microbiome plays a 
notable role in the emergence and development of somatic 
and psychological symptoms in AN. The consideration of 
microbe–gut–brain interactions as risk factors for the onset 
and perpetuation of AN and as a target for therapeutic inter-
ventions, will likely prove to be a significant shift in our 
scientific concept of the aetiology and treatment of eating 
disorders. Until now, there have been very few studies on 
the role of the intestinal microbiome in AN and other eat-
ing disorders. Accordingly, we are not aware of the conse-
quences of a diet rapidly changing in caloric content and 
composition. Future research should include continuous 
monitoring of the microbiome during nutritional rehabilita-
tion, weight gain and hormonal restoration far beyond previ-
ous assessments at only the beginning and end of treatment. 
Our knowledge on the effect of rapid weight gain, changes 
in macronutrients and target weight level on the microbi-
ome and consequent inflammation mechanisms is scant. 
Moreover, our insight into gut–brain interaction, especially 
in adolescent AN, is very limited. However, the exploration 
of gut–brain communication and its alteration, especially in 
the early stages of the disease in adolescence, may be par-
ticularly important for the prognosis of this often long last-
ing and disabling disorder.
Compliance with ethical standards 
Conflict of interest On behalf of all authors, the corresponding author 
states that there is no conflict of interest.
Open Access This article is distributed under the terms of the Crea-
tive Commons Attribution 4.0 International License (http://crea-
tivecommons.org/licenses/by/4.0/), which permits unrestricted use, 
distribution, and reproduction in any medium, provided you give 
appropriate credit to the original author(s) and the source, provide a 
link to the Creative Commons license, and indicate if changes were 
made.
References
 1. Simopoulos AP (2001) The Hippocratic concept of positive 
health in the fifth century BC and in the new millennium. World 
Rev Nutr Diet 89:1–4
 2. American Psychiatric Association (2013) Diagnostic and Statis-
tical Manual of Mental Disorders (DSM-5). American Psychiat-
ric Press
 3. Minuchin S, Baker L, Rosman BL, Liebman R, Milman L, 
Todd TC (1975) A conceptual model of psychosomatic illness 
in children. Family organization and family therapy. Arch Gen 
Psychiatry 32:1031–1038
 4. Herpertz-Dahlmann B, Seitz J, Konrad K (2011) Aetiol-
ogy of anorexia nervosa: from a “psychosomatic family 
model” to a neuropsychiatric disorder? Eur Arch Psychia-
try Clin Neurosci 261(Suppl 2):S177–S181. doi:10.1007/
s00406-011-0246-y
 5. Kaplan AS, Walsh BT, Olmsted M, Attia E, Carter JC, Devlin 
MJ, Pike KM, Woodside B, Rockert W, Roberto CA, Parides 
M (2009) The slippery slope: prediction of successful weight 
maintenance in anorexia nervosa. Psychol Med 39:1037–1045. 
doi:10.1017/s003329170800442x
 6. Misra M, Golden NH, Katzman DK (2016) State of the art sys-
tematic review of bone disease in anorexia nervosa. Int J Eat 
Disord 49:276–292. doi:10.1002/eat.22451
 7. Misra M, Klibanski A (2016) Anorexia nervosa and its asso-
ciated endocrinopathy in young people. Horm Res Paediatr 
85:147–157. doi:10.1159/000443735
 8. Pollice C, Kaye WH, Greeno CG, Weltzin TE (1997) Relation-
ship of depression, anxiety, and obsessionality to state of illness 
in anorexia nervosa. Int J Eat Disord 21:367–376
 9. Meehan KG, Loeb KL, Roberto CA, Attia E (2006) Mood 
change during weight restoration in patients with anorexia ner-
vosa. Int J Eat Disord 39:587–589. doi:10.1002/eat.20337
 10. Chen J, Papies EK, Barsalou LW (2016) A core eating network 
and its modulations underlie diverse eating phenomena. Brain 
Cogn. doi:10.1016/j.bandc.2016.04.004
 11. Sherwin E, Rea K, Dinan TG, Cryan JF (2016) A gut (microbi-
ome) feeling about the brain. Curr Opin Gastroenterol 32:96–
102. doi:10.1097/mog.0000000000000244
 12. Kelly JR, Kennedy PJ, Cryan JF, Dinan TG, Clarke G, Hyland 
NP (2015) Breaking down the barriers: the gut microbiome, 
intestinal permeability and stress-related psychiatric disorders. 
Front Cell Neurosci 9:392. doi:10.3389/fncel.2015.00392
Eur Child Adolesc Psychiatry 
1 3
 13. Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI 
(2005) Host-bacterial mutualism in the human intestine. Sci-
ence 307:1915–1920. doi:10.1126/science.1104816
 14. Derrien M, van Hylckama Vlieg JE (2015) Fate, activity, and 
impact of ingested bacteria within the human gut microbiota. 
Trends Microbiol 23:354–366. doi:10.1016/j.tim.2015.03.002
 15. Petra AI, Panagiotidou S, Hatziagelaki E, Stewart JM, 
Conti P, Theoharides TC (2015) Gut-microbiota-brain axis 
and its effect on neuropsychiatric disorders with suspected 
immune dysregulation. Clin Ther 37:984–995. doi:10.1016/j.
clinthera.2015.04.002
 16. Carr J, Kleiman SC, Bulik CM, Bulik-Sullivan EC, Carroll IM 
(2016) Can attention to the intestinal microbiota improve under-
standing and treatment of anorexia nervosa? Expert Rev Gastro-
enterol Hepatol 10:565–569. doi:10.1586/17474124.2016.1166
953
 17. Steinhausen HC (2002) The outcome of anorexia nervosa in the 
20th century. Am J Psychiatry 159:1284–1293
 18. Arcelus J, Mitchell AJ, Wales J, Nielsen S (2011) Mortality 
rates in patients with anorexia nervosa and other eating dis-
orders. A meta-analysis of 36 studies. Arch Gen Psychiatry 
68:724–731. doi:10.1001/archgenpsychiatry.2011.74
 19. Herpertz-Dahlmann B, van Elburg A, Castro-Fornieles J, 
Schmidt U (2015) ESCAP Expert Paper: new developments in 
the diagnosis and treatment of adolescent anorexia nervosa–a 
European perspective. Eur Child Adolesc Psychiatry 24:1153–
1167. doi:10.1007/s00787-015-0748-7
 20. Schmidt U, Campbell IC (2013) Treatment of eating disorders 
can not remain ‘brainless’: the case for brain-directed treat-
ments. Eur Eat Disord Rev 21:425–427. doi:10.1002/erv.2257
 21. Staubach F, Kunzel S, Baines AC, Yee A, McGee BM, Back-
hed F, Baines JF, Johnsen JM (2012) Expression of the blood-
group-related glycosyltransferase B4galnt2 influences the intes-
tinal microbiota in mice. ISME J 6:1345–1355. doi:10.1038/
ismej.2011.204
 22. Kelly JR, Clarke G, Cryan JF, Dinan TG (2016) Brain-gut-
microbiota axis: challenges for translation in psychiatry. Ann 
Epidemiol 26:366–372. doi:10.1016/j.annepidem.2016.02.008
 23. Vanuytsel T, van Wanrooy S, Vanheel H, Vanormelingen C, 
Verschueren S, Houben E, Salim Rasoel S, Tomicronth J, Hol-
voet L, Farre R, Van Oudenhove L, Boeckxstaens G, Verbeke K, 
Tack J (2014) Psychological stress and corticotropin-releasing 
hormone increase intestinal permeability in humans by a mast 
cell-dependent mechanism. Gut 63:1293–1299. doi:10.1136/
gutjnl-2013-305690
 24. Monteleone AM, Monteleone P, Serino I, Amodio R, Monaco 
F, Maj M (2016) Underweight subjects with anorexia nervosa 
have an enhanced salivary cortisol response not seen in weight 
restored subjects with anorexia nervosa. Psychoneuroendocri-
nology 70:118–121. doi:10.1016/j.psyneuen.2016.05.004
 25. Schorr M, Lawson EA, Dichtel LE, Klibanski A, Miller KK 
(2015) Cortisol measures across the weight spectrum. J Clin 
Endocrinol Metab 100:3313–3321. doi:10.1210/jc.2015-2078
 26. Jesus P, Ouelaa W, Francois M, Riachy L, Guerin C, Aziz M, Do 
Rego JC, Dechelotte P, Fetissov SO, Coeffier M (2014) Alteration 
of intestinal barrier function during activity-based anorexia in 
mice. Clin Nutr 33:1046–1053. doi:10.1016/j.clnu.2013.11.006
 27. Yano JM, Yu K, Donaldson GP, Shastri GG, Ann P, Ma L, Nagler 
CR, Ismagilov RF, Mazmanian SK, Hsiao EY (2015) Indigenous 
bacteria from the gut microbiota regulate host serotonin biosyn-
thesis. Cell 161:264–276. doi:10.1016/j.cell.2015.02.047
 28. Wikoff WR, Anfora AT, Liu J, Schultz PG, Lesley SA, Peters 
EC, Siuzdak G (2009) Metabolomics analysis reveals large 
effects of gut microflora on mammalian blood metabolites. Proc 
Natl Acad Sci 106:3698–3703. doi:10.1073/pnas.0812874106
 29. Ridaura V, Belkaid Y (2015) Gut microbiota: the link to your 
second brain. Cell 161:193–194. doi:10.1016/j.cell.2015.03.033
 30. Jenkins TA, Nguyen JC, Polglaze KE, Bertrand PP (2016) Influ-
ence of tryptophan and serotonin on mood and cognition with 
a possible role of the gut–brain axis. Nutrients. doi:10.3390/
nu8010056
 31. Neufeld KM, Kang N, Bienenstock J, Foster JA (2011) Reduced 
anxiety-like behavior and central neurochemical change in 
germ-free mice. Neurogastroenterol Motil 23(255–264):e119. 
doi:10.1111/j.1365-2982.2010.01620.x
 32. Duman RS (2011) Neurochemical theories of depression: pre-
clinical studies. In: Charney DS, Nestler EJ (eds) Neurobiology 
of mental illness. Oxford Press, pp 414–444
 33. Clarke G, Grenham S, Scully P, Fitzgerald P, Moloney RD, 
Shanahan F, Dinan TG, Cryan JF (2013) The microbiome–gut–
brain axis during early life regulates the hippocampal serotoner-
gic system in a sex-dependent manner. Mol Psychiatry 18:666–
673. doi:10.1038/mp.2012.77
 34. Jiang H, Ling Z, Zhang Y, Mao H, Ma Z, Yin Y, Wang W, Tang 
W, Tan Z, Shi J, Li L, Ruan B (2015) Altered fecal microbiota 
composition in patients with major depressive disorder. Brain 
Behav Immun 48:186–194. doi:10.1016/j.bbi.2015.03.016
 35. Lurie I, Yang YX, Haynes K, Mamtani R, Boursi B (2015) 
Antibiotic exposure and the risk for depression, anxiety, or psy-
chosis: a nested case-control study. J Clin Psychiatry 76:1522–
1528. doi:10.4088/JCP.15m09961
 36. Kaye WH, Fudge JL, Paulus M (2009) New insights into symp-
toms and neurocircuit function of anorexia nervosa. Nat Rev 
Neurosci 10:573–584. doi:10.1038/nrn2682
 37. Kaye WH, Wierenga CE, Bailer UF, Simmons AN, Bischoff-
Grethe A (2013) Nothing tastes as good as skinny feels: the 
neurobiology of anorexia nervosa. Trends Neurosci 36:110–
120. doi:10.1016/j.tins.2013.01.003
 38. Herpertz-Dahlmann B, Wewetzer C (2014) Eating disorders. In: 
Gerlach M, Warnke A, Greenhill L (eds) Psychiatric drugs in 
children and adolescents. Springer, Heidelberg, pp 429–437
 39. Harrisberger F, Smieskova R, Schmidt A, Lenz C, Walter A, 
Wittfeld K, Grabe HJ, Lang UE, Fusar-Poli P, Borgwardt S 
(2015) BDNF Val66Met polymorphism and hippocampal 
volume in neuropsychiatric disorders: a systematic review 
and meta-analysis. Neurosci Biobehav Rev 55:107–118. 
doi:10.1016/j.neubiorev.2015.04.017
 40. Desbonnet L, Clarke G, Traplin A, O’Sullivan O, Crispie F, 
Moloney RD, Cotter PD, Dinan TG, Cryan JF (2015) Gut 
microbiota depletion from early adolescence in mice: implica-
tions for brain and behaviour. Brain Behav Immun 48:165–173. 
doi:10.1016/j.bbi.2015.04.004
 41. Savignac HM, Corona G, Mills H, Chen L, Spencer JP, Tzortzis 
G, Burnet PW (2013) Prebiotic feeding elevates central brain 
derived neurotrophic factor, N-methyl-d-aspartate receptor sub-
units and d-serine. Neurochem Int 63:756–764. doi:10.1016/j.
neuint.2013.10.006
 42. Liang S, Wang T, Hu X, Luo J, Li W, Wu X, Duan Y, Jin 
F (2015) Administration of Lactobacillus helveticus NS8 
improves behavioral, cognitive, and biochemical aberrations 
caused by chronic restraint stress. Neuroscience 310:561–577. 
doi:10.1016/j.neuroscience.2015.09.033
 43. Savignac HM, Tramullas M, Kiely B, Dinan TG, Cryan JF 
(2015) Bifidobacteria modulate cognitive processes in an anx-
ious mouse strain. Behav Brain Res 287:59–72. doi:10.1016/j.
bbr.2015.02.044
 44. Monteleone P, Fabrazzo M, Martiadis V, Serritella C, Pannuto 
M, Maj M (2005) Circulating brain-derived neurotrophic fac-
tor is decreased in women with anorexia and bulimia nervosa 
but not in women with binge-eating disorder: relationships to 
 Eur Child Adolesc Psychiatry
1 3
co-morbid depression, psychopathology and hormonal vari-
ables. Psychol Med 35:897–905
 45. Zwipp J, Hass J, Schober I, Geisler D, Ritschel F, Seidel M, 
Weiss J, Roessner V, Hellweg R, Ehrlich S (2014) Serum 
brain-derived neurotrophic factor and cognitive functioning in 
underweight, weight-recovered and partially weight-recovered 
females with anorexia nervosa. Prog Neuropsychopharmacol 
Biol Psychiatry 54:163–169. doi:10.1016/j.pnpbp.2014.05.006
 46. Mohle L, Mattei D, Heimesaat MM, Bereswill S, Fischer A, 
Alutis M, French T, Hambardzumyan D, Matzinger P, Dunay 
IR, Wolf SA (2016) Ly6C(hi) monocytes provide a link between 
antibiotic-induced changes in gut microbiota and adult hip-
pocampal neurogenesis. Cell Rep 15:1945–1956. doi:10.1016/j.
celrep.2016.04.074
 47. Martin-Subero M, Anderson G, Kanchanatawan B, Berk M, 
Maes M (2016) Comorbidity between depression and inflam-
matory bowel disease explained by immune-inflammatory, 
oxidative, and nitrosative stress; tryptophan catabolite; and 
gut–brain pathways. CNS Spectr 21:184–198. doi:10.1017/
s1092852915000449
 48. Bailey MT, Dowd SE, Galley JD, Hufnagle AR, Allen RG, Lyte 
M (2011) Exposure to a social stressor alters the structure of the 
intestinal microbiota: implications for stressor-induced immu-
nomodulation. Brain Behav Immun 25:397–407. doi:10.1016/j.
bbi.2010.10.023
 49. Maes M, Kubera M, Leunis JC, Berk M (2012) Increased 
IgA and IgM responses against gut commensals in chronic 
depression: further evidence for increased bacterial transloca-
tion or leaky gut. J Affect Disord 141:55–62. doi:10.1016/j.
jad.2012.02.023
 50. Raevuori A, Haukka J, Vaarala O, Suvisaari JM, Gissler M, 
Grainger M, Linna MS, Suokas JT (2014) The increased risk 
for autoimmune diseases in patients with eating disorders. PLoS 
One 9:e104845. doi:10.1371/journal.pone.0104845
 51. Frost GS, Walton GE, Swann JR, Psichas A, Costabile A, John-
son LP, Sponheimer M, Gibson GR, Barraclough TG (2014) 
Impacts of plant-based foods in ancestral hominin diets on 
the metabolism and function of gut microbiota in vitro. MBio 
5:e00853–e00814. doi:10.1128/mBio.00853-14
 52. den Besten G, van Eunen K, Groen AK, Venema K, Reijngoud 
DJ, Bakker BM (2013) The role of short-chain fatty acids in the 
interplay between diet, gut microbiota, and host energy metabo-
lism. J Lipid Res 54:2325–2340. doi:10.1194/jlr.R036012
 53. Stilling RM, Bordenstein SR, Dinan TG, Cryan JF (2014) 
Friends with social benefits: host-microbe interactions as a 
driver of brain evolution and development? Front Cell Infect 
Microbiol 4:147. doi:10.3389/fcimb.2014.00147
 54. Stilling RM, Dinan TG, Cryan JF (2014) Microbial genes, 
brain & behaviour—epigenetic regulation of the gut–brain axis. 
Genes Brain Behav 13:69–86. doi:10.1111/gbb.12109
 55. De Vadder F, Kovatcheva-Datchary P, Goncalves D, Vin-
era J, Zitoun C, Duchampt A, Backhed F, Mithieux G (2014) 
Microbiota-generated metabolites promote metabolic benefits 
via gut–brain neural circuits. Cell 156:84–96. doi:10.1016/j.
cell.2013.12.016
 56. Byrne CS, Chambers ES, Morrison DJ, Frost G (2015) The 
role of short chain fatty acids in appetite regulation and energy 
homeostasis. Int J Obes (Lond) 39:1331–1338. doi:10.1038/
ijo.2015.84
 57. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, 
Gordon JI (2006) An obesity-associated gut microbiome with 
increased capacity for energy harvest. Nature 444:1027–1031. 
doi:10.1038/nature05414
 58. Ridaura VK, Faith JJ, Rey FE, Cheng J, Duncan AE, Kau AL, 
Griffin NW, Lombard V, Henrissat B, Bain JR, Muehlbauer 
MJ, Ilkayeva O, Semenkovich CF, Funai K, Hayashi DK, Lyle 
BJ, Martini MC, Ursell LK, Clemente JC, Van Treuren W, 
Walters WA, Knight R, Newgard CB, Heath AC, Gordon JI 
(2013) Gut microbiota from twins discordant for obesity modu-
late metabolism in mice. Science 341:1241214. doi:10.1126/
science.1241214
 59. Smith MI, Yatsunenko T, Manary MJ, Trehan I, Mkakosya R, 
Cheng J, Kau AL, Rich SS, Concannon P, Mychaleckyj JC, Liu 
J, Houpt E, Li JV, Holmes E, Nicholson J, Knights D, Ursell 
LK, Knight R, Gordon JI (2013) Gut microbiomes of Malawian 
twin pairs discordant for kwashiorkor. Science 339:548–554. 
doi:10.1126/science.1229000
 60. Adan RA, Hillebrand JJ, De Rijke C, Nijenhuis W, Vink T, Gar-
ner KM, Kas MJ (2003) Melanocortin system and eating disor-
ders. Ann N Y Acad Sci 994:267–274
 61. Monteleone P, Carratu R, Carteni M, Generoso M, Lamberti M, 
Magistris LD, Brambilla F, Colurcio B, Secondulfo M, Maj M 
(2004) Intestinal permeability is decreased in anorexia nervosa. 
Mol Psychiatry 9:76–80. doi:10.1038/sj.mp.4001374
 62. Uil JJ, van Elburg RM, van Overbeek FM, Mulder CJ, VanBerge-
Henegouwen GP, Heymans HS (1997) Clinical implications of 
the sugar absorption test: intestinal permeability test to assess 
mucosal barrier function. Scand J Gastroenterol Suppl 223:70–78
 63. Pals KL, Chang RT, Ryan AJ, Gisolfi CV (1997) Effect of run-
ning intensity on intestinal permeability. J Appl Physiol (1985) 
82:571–576
 64. Elia M, Behrens R, Northrop C, Wraight P, Neale G (1987) 
Evaluation of mannitol, lactulose and 51Cr-labelled ethylenedi-
aminetetra-acetate as markers of intestinal permeability in man. 
Clin Sci (Lond) 73:197–204
 65. Welsh FK, Farmery SM, MacLennan K, Sheridan MB, Barclay 
GR, Guillou PJ, Reynolds JV (1998) Gut barrier function in 
malnourished patients. Gut 42:396–401
 66. Pfleiderer A, Lagier JC, Armougom F, Robert C, Vialettes B, 
Raoult D (2013) Culturomics identified 11 new bacterial species 
from a single anorexia nervosa stool sample. Eur J Clin Micro-
biol Infect Dis 32:1471–1481. doi:10.1007/s10096-013-1900-2
 67. Morita H, Obata K, Abe C, Shiba D, Shirakawa M, Kudo T, 
Takahashi S (2015) Feasibility of a short-arm centrifuge for 
mouse hypergravity experiments. PLoS One 10:e0133981. 
doi:10.1371/journal.pone.0133981
 68. Armougom F, Henry M, Vialettes B, Raccah D, Raoult D 
(2009) Monitoring bacterial community of human gut micro-
biota reveals an increase in Lactobacillus in obese patients 
and methanogens in anorexic patients. PLoS One 4:e7125. 
doi:10.1371/journal.pone.0007125
 69. Kleiman SC, Watson HJ, Bulik-Sullivan EC, Huh EY, Taran-
tino LM, Bulik CM, Carroll IM (2015) The intestinal micro-
biota in acute anorexia nervosa and during renourishment: 
relationship to depression, anxiety, and eating disorder psy-
chopathology. Psychosom Med 77:969–981. doi:10.1097/
psy.0000000000000247
 70. Mack I, Cuntz U, Gramer C, Niedermaier S, Pohl C, Schwiertz 
A, Zimmermann K, Zipfel S, Enck P, Penders J (2016) Weight 
gain in anorexia nervosa does not ameliorate the faecal micro-
biota, branched chain fatty acid profiles, and gastrointestinal 
complaints. Sci Rep 6:26752. doi:10.1038/srep26752
 71. Holzer P, Farzi A (2014) Neuropeptides and the micro-
biota-gut–brain axis. Adv Exp Med Biol 817:195–219. 
doi:10.1007/978-1-4939-0897-4_9
 72. Smink FR, van Hoeken D, Hoek HW (2013) Epidemiology, 
course, and outcome of eating disorders. Curr Opin Psychiatry 
26:543–548. doi:10.1097/YCO.0b013e328365a24f
 73. Neuman H, Debelius JW, Knight R, Koren O (2015) Micro-
bial endocrinology: the interplay between the microbiota and 
the endocrine system. FEMS Microbiol Rev 39:509–521. 
doi:10.1093/femsre/fuu010
Eur Child Adolesc Psychiatry 
1 3
 74. Terashi M, Asakawa A, Harada T, Ushikai M, Coquerel Q, 
Sinno MH, Dechelotte P, Inui A, Fetissov SO (2011) Ghrelin 
reactive autoantibodies in restrictive anorexia nervosa. Nutrition 
27:407–413. doi:10.1016/j.nut.2011.01.002
 75. Fetissov SO, Crook MA (2011) What increased consumption of 
licorice may reveal in anorexia nervosa. Nutrition 27:853–854. 
doi:10.1016/j.nut.2011.05.004
 76. Corcos M, Guilbaud O, Paterniti S, Moussa M, Chambry J, 
Chaouat G, Consoli SM, Jeammet P (2003) Involvement of 
cytokines in eating disorders: a critical review of the human lit-
erature. Psychoneuroendocrinology 28:229–249
 77. Solmi M, Veronese N, Favaro A, Santonastaso P, Manzato 
E, Sergi G, Correll CU (2015) Inflammatory cytokines and 
anorexia nervosa: a meta-analysis of cross-sectional and lon-
gitudinal studies. Psychoneuroendocrinology 51:237–252. 
doi:10.1016/j.psyneuen.2014.09.031
 78. Solmi M, Santonastaso P, Caccaro R, Favaro A (2013) A case 
of anorexia nervosa with comorbid Crohn’s disease: beneficial 
effects of anti-TNF-alpha therapy? Int J Eat Disord 46:639–
641. doi:10.1002/eat.22153
 79. Lee KN, Lee OY (2014) Intestinal microbiota in pathophysiol-
ogy and management of irritable bowel syndrome. World J Gas-
troenterol 20:8886–8897. doi:10.3748/wjg.v20.i27.8886
 80. Rajilic-Stojanovic M, Jonkers DM, Salonen A, Hanevik K, 
Raes J, Jalanka J, de Vos WM, Manichanh C, Golic N, Enck P, 
Philippou E, Iraqi FA, Clarke G, Spiller RC, Penders J (2015) 
Intestinal microbiota and diet in IBS: causes, consequences, or 
epiphenomena? Am J Gastroenterol 110:278–287. doi:10.1038/
ajg.2014.427
 81. Herpertz-Dahlmann B (2015) Adolescent eating disorders: 
update on definitions, symptomatology, epidemiology, and 
comorbidity. Child Adolesc Psychiatr Clin N Am 24:177–196. 
doi:10.1016/j.chc.2014.08.003
 82. Million M, Angelakis E, Maraninchi M, Henry M, Giorgi R, 
Valero R, Vialettes B, Raoult D (2013) Correlation between 
body mass index and gut concentrations of Lactobacillus reu-
teri, Bifidobacterium animalis, Methanobrevibacter smithii and 
Escherichia coli. Int J Obes (Lond) 37:1460–1466. doi:10.1038/
ijo.2013.20
 83. Marzola E, Panepinto C, Delsedime N, Amianto F, Fassino S, 
Abbate-Daga G (2016) A factor analysis of the meanings of 
anorexia nervosa: intrapsychic, relational, and avoidant dimen-
sions and their clinical correlates. BMC Psychiatry 16:190. 
doi:10.1186/s12888-016-0894-6
 84. Kleiman SC, Carroll IM, Tarantino LM, Bulik CM (2015) Gut 
feelings: a role for the intestinal microbiota in anorexia ner-
vosa? Int J Eat Disord 48:449–451. doi:10.1002/eat.22394
 85. Goffredo M, Mass K, Parks EJ, Wagner DA, McClure EA, Graf 
J, Savoye M, Pierpont B, Cline G, Santoro N (2016) Role of 
gut microbiota and short chain fatty acids in modulating energy 
harvest and fat partitioning in youth. J Clin Endocrinol Metab 
101:4367–4376. doi:10.1210/jc.2016-1797
 86. Jumpertz R, Le DS, Turnbaugh PJ, Trinidad C, Bogardus C, 
Gordon JI, Krakoff J (2011) Energy-balance studies reveal 
associations between gut microbes, caloric load, and nutrient 
absorption in humans. Am J Clin Nutr 94:58–65. doi:10.3945/
ajcn.110.010132
 87. Martinez KB, Pierre JF, Chang EB (2016) The gut microbiota: 
the gateway to improved metabolism. Gastroenterol Clin N Am 
45:601–614. doi:10.1016/j.gtc.2016.07.001
 88. Salonen A, de Vos WM (2014) Impact of diet on human intesti-
nal microbiota and health. Annu Rev Food Sci Technol 5:239–
262. doi:10.1146/annurev-food-030212-182554
 89. Walker AW, Ince J, Duncan SH, Webster LM, Holtrop G, Ze 
X, Brown D, Stares MD, Scott P, Bergerat A, Louis P, McIn-
tosh F, Johnstone AM, Lobley GE, Parkhill J, Flint HJ (2011) 
Dominant and diet-responsive groups of bacteria within the 
human colonic microbiota. ISME J 5:220–230. doi:10.1038/
ismej.2010.118
 90. David LA, Maurice CF, Carmody RN, Gootenberg DB, Button 
JE, Wolfe BE, Ling AV, Devlin AS, Varma Y, Fischbach MA, 
Biddinger SB, Dutton RJ, Turnbaugh PJ (2014) Diet rapidly 
and reproducibly alters the human gut microbiome. Nature 
505:559–563. doi:10.1038/nature12820
 91. Devkota S, Wang Y, Musch MW, Leone V, Fehlner-Peach H, 
Nadimpalli A, Antonopoulos DA, Jabri B, Chang EB (2012) 
Dietary-fat-induced taurocholic acid promotes pathobiont 
expansion and colitis in Il10−/− mice. Nature 487:104–108. 
doi:10.1038/nature11225
 92. Misra M, Tsai P, Anderson EJ, Hubbard JL, Gallagher K, Soyka 
LA, Miller KK, Herzog DB, Klibanski A (2006) Nutrient intake 
in community-dwelling adolescent girls with anorexia nervosa 
and in healthy adolescents. Am J Clin Nutr 84:698–706
 93. Gibson GR, Roberfroid MB (1995) Dietary modulation of the 
human colonic microbiota: introducing the concept of prebiot-
ics. J Nutr 125:1401–1412
 94. https://en.wikipedia.org/wiki/Wikipedia:WikiProject_Wikipedia/
Assessment
 95. Hutkins RW, Krumbeck JA, Bindels LB, Cani PD, Fahey 
G Jr, Goh YJ, Hamaker B, Martens EC, Mills DA, Rastal 
RA, Vaughan E, Sanders ME (2016) Prebiotics: why defini-
tions matter. Curr Opin Biotechnol 37:1–7. doi:10.1016/j.
copbio.2015.09.001
 96. Zhong Y, Cai D, Cai W, Geng S, Chen L, Han T (2009) Pro-
tective effect of galactooligosaccharide-supplemented enteral 
nutrition on intestinal barrier function in rats with severe 
acute pancreatitis. Clin Nutr 28:575–580. doi:10.1016/j.
clnu.2009.04.026
 97. Mika A, Greenwood B N, Chichlowski M, Borchert D, Hulen K 
A, Berg B et al (2014) Dietary prebiotics increase Bifidobacte-
rium spp. and Lactobacillus spp. in the gut and promote stress 
resistance. Brain Behav Immun 40(Supplement). doi:10.1016/j.
bbi.2014.06.175
 98. Schmidt K, Cowen PJ, Harmer CJ, Tzortzis G, Errington S, 
Burnet PW (2015) Prebiotic intake reduces the waking cor-
tisol response and alters emotional bias in healthy volun-
teers. Psychopharmacology 232:1793–1801. doi:10.1007/
s00213-014-3810-0
 99. Savignac HM, Kiely B, Dinan TG, Cryan JF (2014) Bifido-
bacteria exert strain-specific effects on stress-related behavior 
and physiology in BALB/c mice. Neurogastroenterol Motil 
26:1615–1627. doi:10.1111/nmo.12427
 100. Mazurak N, Broelz E, Storr M, Enck P (2015) Probiotic ther-
apy of the irritable bowel syndrome: why is the evidence still 
poor and what can be done about It? J Neurogastroenterol Motil 
21:471–485. doi:10.5056/jnm15071
 101. Kristensen NB, Bryrup T, Allin KH, Nielsen T, Hansen TH, 
Pedersen O (2016) Alterations in fecal microbiota composi-
tion by probiotic supplementation in healthy adults: a system-
atic review of randomized controlled trials. Genome Med 8:52. 
doi:10.1186/s13073-016-0300-5
 102. Sheridan PO, Bindels LB, Saulnier DM, Reid G, Nova E, 
Holmgren K, O’Toole PW, Bunn J, Delzenne N, Scott KP 
(2014) Can prebiotics and probiotics improve therapeutic out-
comes for undernourished individuals? Gut Microbes 5:74–82. 
doi:10.4161/gmic.27252
